Status:
RECRUITING
Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy
Lead Sponsor:
University of Florida
Conditions:
Seizures
Eligibility:
All Genders
Up to 50 years
Phase:
NA
Brief Summary
Approximately a fourth of children with seizures do not respond adequately to available therapy. Ketogenic therapy has a long history as treatment for intractable epilepsy, but there is no agreement c...
Detailed Description
The basis of Ketogenic Therapy is an altered macronutrient intake. It is based on a ratio of fat: protein+carbohydrate in which protein intake is adequate and carbohydrate is minimal. On Ketogenic The...
Eligibility Criteria
Inclusion
- Patients whose physician has prescribed the ketogenic diet
- Patients with lab tests consistent with the ability to metabolize a high fat and low carbohydrate diet
- Patients that can be compliant with administration of the therapy and with record keeping.
Exclusion
- Patients with lab tests consistent with the inability to metabolize a high fat and low carbohydrate diet
- Patients at risk of being non-compliant with administration of the therapy and with record keeping
Key Trial Info
Start Date :
September 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2031
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT02216500
Start Date
September 1 2006
End Date
October 1 2031
Last Update
July 11 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Florida
Gainesville, Florida, United States, 32611